<DOC>
	<DOCNO>NCT00251550</DOCNO>
	<brief_summary>To investigate efficacy safety pemetrexed combined cisplatin chemo-naive patient Malignant Pleural Mesothelioma .</brief_summary>
	<brief_title>Study Pemetrexed Plus Cisplatin Patients With Malignant Pleural Mesothelioma</brief_title>
	<detailed_description />
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Inapplicable radical operation Not receive prior systemic chemotherapy Performance status : 01 Having history sensitivity platinum agent , folic acid vitamin B12</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>